Key spatial publications using RNAscope ™ technology! Dive into the latest research interrogating cellular heterogeneity across various research areas. Learn from spatial experts, explore groundbreaking discoveries, and unlock new insights using the RNAscope technology. Watch Now : https://bit.ly/4djTKwr #spatialbiology #publication #singlecell #RNAscopeISH
Bio-Techne
Biotechnology Research
Minneapolis, Minnesota 48,921 followers
Empowering scientists & clinicians by providing high-quality reagents, analytical instruments, & precision diagnostics.
About us
Bio-Techne is headquartered in Minneapolis, Minnesota and employs over 3,000 people globally at 34 locations worldwide. As a global developer, manufacturer and supplier of high-quality reagents, analytical instruments and precision diagnostics, Bio-Techne has an extensive catalog of over 500,000 products. Incorporated in 1981 as R&D Systems, the company changed its name to Bio-Techne in 2014. Our growth has been accelerated through acquisitions, organic investments, diversification of our customer base and expansion into new markets. In fiscal year 2023, Bio-Techne delivered net sales of over $1.1 billion. Bio-Techne includes the following brands: ACD, Asuragen, ExosomeDx, Lunaphore, Novus Biologicals, ProteinSimple, R&D Systems and Tocris Bioscience.
- Website
-
http://www.bio-techne.com/
External link for Bio-Techne
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Minneapolis, Minnesota
- Type
- Public Company
Locations
-
Primary
614 McKinley Place NE
Minneapolis, Minnesota 55413, US
Employees at Bio-Techne
Updates
-
We're at #CHIBioprocessingSummit next week! Join our insightful talks and visit booth #422 to discover how you can streamline your bioprocesses and seamlessly scale toward commercialization. Optimize your cell cultures: https://bit.ly/3yLw3ht Explore protein characterization solutions: https://bit.ly/3AwDgm1
-
Resolution matters, context matters. Learn more about how Dr. Ruchi Komal from National Institute of Mental Health (NIMH) at The National Institutes of Health leveraged the high spatial resolution of RNAscope technology to reveal the spatial heterogeneity and neuronal structures of the brain's suprachiasmatic nucleus. https://bit.ly/3M3YSc7 #RNAscope #spatialtranscriptomics #spatialgenomics #neuroscience #SCN #circadian #insitu #singlecell #RNA
-
-
Take your research to the next level – share it with colleagues from across the globe at Neuroscience 2024. Apply to win one of four travel grants to help you get there. Apply here: bit.ly/3zJ2Js4 #Neuroscience2024 #Neuroscienceresearch
-
PEI STAR-Go™ is a ready-to-use aqueous formulation of our high performance PEI STAR™ transfection reagent, provided as a sterile-filtered solution https://bit.ly/4c830lR
-
-
We're thrilled to welcome Morgan Bourgeois, Hadyn Garelick, and Christin Markarian to our amazing team of RNAscope Spatial Sales Experts! With their diverse scientific backgrounds, charming personalities, and long industry experience, they're set to bring fresh energy and innovation to our spatial commercial team. We look forward to the impact they will make in the spatial community and support the company’s goal in driving innovation to fuel scientific discoveries. #TeamACD #SpatialBiology #CompanyCulture #SalesTeam #RNAscope
-
-
Bio-Techne is excited to participate in Spear Bio’s $45 million Series A funding round. Founded by Feng Xuan and Peng Yin, Spear Bio is a leader in the development and manufacture of ultra-sensitive immunoassays capable of measuring protein biomarkers at attomolar level from sub-microliter sample volume. Its technology is ideal for historically challenging low abundant biomarkers in neurology, inflammation and oncology. The initial offering will focus on key biomarkers supporting translational research in Alzheimer’s disease. Read more: https://lnkd.in/gY9KqgUa
Bio-Techne is excited to participate in Spear Bio’s $45 million Series A funding round. Founded by Feng Xuan and Peng Yin, Spear Bio is a leader in the development and manufacture of ultra-sensitive immunoassays capable of measuring protein biomarkers at attomolar level from sub-microliter sample volume. Its technology is ideal for historically challenging low abundant biomarkers in neurology, inflammation and oncology. The initial offering will focus on key biomarkers supporting translational research in Alzheimer’s disease. I can't wait to see how the Spear Bio team positively impacts human health!
-
-
The landscape of western analysis is being transformed! We are excited to announce a new instrument in the Simple Western lineup to make it easier for you in your research to get quality results faster- Meet Leo https://lnkd.in/g5RueieY #ProteinSimple #SimpleWestern #BioTechne #MeetLeo #WesternAnalysis
-
Introducing the next leap in Simple Western™ technology: www.bio-techne.com/leo | Video Begins at 5:50 The Leo™ System, powered by Simple Western™ Technology, is a high-throughput, fully automated capillary western platform. It enables fast, simple, and sensitive protein quantification and detection, processing up to 100 samples per run, increasing experimental size for quantitative assay designs and delivering results in as little as 3 hours.
Launch Event: Move Beyond Traditional Western Blots with Leo™
www.linkedin.com
-
Take your research to the next level – share it with colleagues from across the globe at Neuroscience 2024. Apply to win one of four travel grants to help you get there. Apply here: bit.ly/3zJ2Js4 #Neuroscience2024 #Neuroscienceresearch
Now Open! Apply for Bio-Techne's Neuroscience 2024 Travel Grant Program
info.bio-techne.com